Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial - PubMed (original) (raw)

Clinical Trial

Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial

Johannes Zacherl et al. Surg Endosc. 2015 Jan.

Abstract

Background: Both long-term proton pump inhibitor (PPI) use and surgical fundoplication have potential drawbacks as treatments for chronic gastroesophageal reflux disease (GERD). This multi-center, prospective study evaluated the clinical experiences of 69 patients who received an alternative treatment: endoscopic anterior fundoplication with a video- and ultrasound-guided transoral surgical stapler.

Methods: Patients with well-categorized GERD were enrolled at six international sites. Efficacy data was compared at baseline and at 6 months post-procedure. The primary endpoint was a ≥ 50 % improvement in GERD health-related quality of life (HRQL) score. Secondary endpoints were elimination or ≥ 50 % reduction in dose of PPI medication and reduction of total acid exposure on esophageal pH probe monitoring. A safety evaluation was performed at time 0 and weeks 1, 4, 12, and 6 months.

Results: 66 patients completed follow-up. Six months after the procedure, the GERD-HRQL score improved by >50 % off PPI in 73 % (48/66) of patients (95 % CI 60-83 %). Forty-two patients (64.6 %) were no longer using daily PPI medication. Of the 23 patients who continued to take PPI following the procedure, 13 (56.5 %) reported a ≥ 50 % reduction in dose. The mean percent of total time with esophageal pH <4.0 decreased from baseline to 6 months (P < 0.001). Common adverse events were peri-operative chest discomfort and sore throat. Two severe adverse events requiring intervention occurred in the first 24 subjects, no further esophageal injury or leaks were reported in the remaining 48 enrolled subjects.

Conclusions: The initial 6-month data reported in this study demonstrate safety and efficacy of this endoscopic plication device. Early experience with the device necessitated procedure and device changes to improve safety, with improved results in the later portion of the study. Continued assessment of durability and safety are ongoing in a three-year follow-up study of this patient group.

Trial registration: ClinicalTrials.gov NCT00734747.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

A–C Medigus transoral surgical stapler: A Full flexible endostapler, OD 15.5 mm B Distal tip C positioning of cartridge 3 cm proximal to gastroesophageal junction for stapling

Fig. 2

Fig. 2

Step by step endoscopic images of a procedure involving the placement of three quintuplets of staples (15 staples total) to create an effective gastroesophageal flap valve

Fig. 3

Fig. 3

Boxplots of GERD-HRQL median scores at baseline (N = 66) and 6 months post-procedure (N = 64)

References

    1. Dent J, Holloway RH, Toouli J, Dodds WJ. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut. 1988;29:1020–1028. doi: 10.1136/gut.29.8.1020. -DOI -PMC -PubMed
    1. Tack J, Becher A, Mulligan C, Johnson DA. Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life. Aliment Pharmacol Ther. 2012;35:1257–1266. doi: 10.1111/j.1365-2036.2012.05086.x. -DOI -PubMed
    1. Fass R. Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. Drugs. 2007;67:1521–1530. doi: 10.2165/00003495-200767110-00001. -DOI -PubMed
    1. Lu M, Malladi V, Agha A, Abydayyeh S, Han C, Siepman N, Graham DY. Failures in a proton pump inhibitor therapeutic substitution program: lessons learned. Dig Dis Sci. 2007;2052:2813–2820. doi: 10.1007/s10620-007-9811-7. -DOI -PubMed
    1. Clayton SB, Rife CC, Singh ER, Kalbfleisch JH, Castell DO. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing. Dis Esophagus. 2012;25:682–686. doi: 10.1111/j.1442-2050.2011.01310.x. -DOI -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources